PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.216
https://www.valueinhealthjournal.com/article/S1098-3015(18)33516-2/fulltext
Title :
PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33516-2&doi=10.1016/j.jval.2018.09.216
First page :
Section Title :
Open access? :
No
Section Order :
1557